Immunology

J.G. Bodmer, S.G.E. Marsh, E. Albert, "Nomenclature for factors of the HLA system, 1989," Immunology Today, 11, 3-10, January 1990. Julia Bodmer (Imperial Cancer Research Fund, London): "`What's in a name? That which we call a rose / By any other name would smell as sweet.' Shakespeare was right only in pointing out that it does not matter whether we call the flower a rose or a widget. The important thing is that we all call it by the same name. The 1989 nomenclature report is the ninth in a

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

J.G. Bodmer, S.G.E. Marsh, E. Albert, "Nomenclature for factors of the HLA system, 1989," Immunology Today, 11, 3-10, January 1990.

Julia Bodmer (Imperial Cancer Research Fund, London): "`What's in a name? That which we call a rose / By any other name would smell as sweet.' Shakespeare was right only in pointing out that it does not matter whether we call the flower a rose or a widget. The important thing is that we all call it by the same name. The 1989 nomenclature report is the ninth in a series, starting in 1967, that has effectively defined, by consensus, the development of the field of human histocompatibility. Early reports were based on serology, defining alleles and loci and the relationship between them. Later reports named cellularly defined specificities. This 1989 report, to be updated annually, deals solely with the naming of HLA genes and alleles identified by molecular methods ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies